Frankfurt - Delayed Quote EUR

Vertex Pharmaceuticals Incorporated (VX1.F)

388.15

-0.80

(-0.21%)

As of 8:02:48 AM GMT+2. Market Open.

2 Top Stocks to Buy Right Now

Berkshire Hathaway remains an attractive investment despite its upcoming leadership change. Vertex Pharmaceuticals has room to grow in its core market and continues to innovate in new areas. Two great examples are Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) and Vertex Pharmaceuticals (NASDAQ: VRTX).

Motley Fool 2 days ago

VRTX
Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Biogen (NASDAQ:BIIB).

StockStory 4 days ago

BIIB

UTHR

VRTX
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment -- and that’s set to continue thanks to the company's innovation. The three major indexes slid in March and April as investors worried about the impact of President Donald Trump's import tariffs on the economy -- but in recent weeks, optimism about lower, more manageable tariff levels has grown. Trump struck a deal with the U.K. and has signed an initial agreement with China, signs that the impact of tariffs may be limited.

Motley Fool 6 days ago

VRTX
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.

StockStory 7 days ago

MYGN

BMRN

UTHR
3 Top Growth Stocks to Buy in the Second Half of 2025

Amazon could hold up better than many expect if steep tariffs remain in place. Meta Platforms should benefit from multiple AI tailwinds. Vertex Pharmaceuticals has two new drugs on the market, with more potentially on the way.

Motley Fool 8 days ago

VRTX

META

AMZN
2 Monster Growth Stocks to Buy and Hold for 10 Years

Shopify should benefit from the switch to e-commerce thanks to its strong position and competitive edge. Vertex Pharmaceuticals' expanding lineup and deep pipeline can help it overcome recent headwinds. Despite recent market volatility, buying shares of top companies that can at least match average returns through 2035 -- or do much better -- is still worth it.

Motley Fool 9 days ago

SHOP

VRTX
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Vertex Pharmaceuticals should have big winners with pain drug Journavx and two promising pipeline candidates. Summit Therapeutics is poised for major success with its cancer immunotherapy, ivonescimab. People need healthcare products and services regardless of what's happening with the economy.

Motley Fool 13 days ago

VRTX

SMMT

IOVA
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

CRISPR Therapeutics stock is down more than 80% from the peak it reached in 2021. The first drug from CRISPR Therapeutics launched early last year, but annualized sales are still less than $60 million. CRISPR Therapeutics recently reported promising early-stage clinical trial results for a cholesterol-reducing treatment.

Motley Fool 14 days ago

CRSP

VRTX
VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of $11.88 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $4.06 per share was 5.4% below analysts’ consensus estimates.

StockStory 15 days ago

VRTX
The Top Corporate Board Directors

Who are the most influential directors at big publicly traded U.S. companies? The first annual Wall Street Journal ranking identifies 251 of them.

The Wall Street Journal 15 days ago

LMT

CVX

CAT
Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

Warren Buffett has guided Berkshire Hathaway through U.S. stock market investing for 59 years. Buffett’s investing has spanned all market environments. The top investor continues to believe in the future of American companies -- and their stock performance.

Motley Fool 16 days ago

CHWY

KO

AXP
Exploring High Growth Tech Stocks in the US Market

The United States market is experiencing a positive trend, with major indices like the S&P 500 and Dow Jones Industrial Average posting significant weekly gains, buoyed by investor optimism following tariff reductions between the U.S. and China. In this environment of renewed enthusiasm for tech stocks, identifying high-growth opportunities involves looking at companies that are well-positioned to capitalize on technological advancements and market demands while navigating potential economic...

Simply Wall St. 17 days ago

GDS

VRTX

EXEL
Value Opportunities: Stocks Estimated Below Intrinsic Worth For May 2025

The United States market has experienced a notable upswing, rising 4.5% over the last week and showing an 11% increase over the past year, with earnings projected to grow by 14% annually. In such a climate, identifying stocks that are estimated to be below their intrinsic worth can present valuable opportunities for investors seeking to capitalize on potential growth while maintaining a focus on value.

Simply Wall St. 18 days ago

VRTX

CPAY

DLO
1 Large-Cap Stock to Target This Week and 2 to Question

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

StockStory 18 days ago

T

VRTX

LULU
Vertex to Participate in Upcoming Investor Conferences

BOSTON, May 15, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.

Business Wire 18 days ago

VRTX
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

CRISPR Therapeutics has an approved gene-therapy treatment still in its early growth stages. One of them is CRISPR Therapeutics (NASDAQ: CRSP). Its financials haven't been looking all that impressive and as a result, growth investors have been dumping the stock.

Motley Fool 20 days ago

CRSP

VRTX
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including United Therapeutics (NASDAQ:UTHR) and its peers.

StockStory 20 days ago

UTHR

ABBV

SRPT
2 Biotech Stocks That Are Screaming Buys in May

Two biotech stocks make perfect candidates for this sort of strategy right now. Let's take a close look at these two biotech stocks that are screaming buys in May. The launch and revenue growth processes take longer for such a product than for standard medicines because gene editing involves several steps.

Motley Fool 21 days ago

CRSP

VRTX
This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Vertex Pharmaceuticals' shares dropped due to poor first-quarter results. Vertex's business and prospects remain attractive. Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update.

Motley Fool 21 days ago

VRTX
Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Vertex Pharmaceuticals is diversifying its already strong lineup of medicines. Axsome Therapeutics has multiple clinical and regulatory catalysts on the way. Two excellent candidates are Vertex Pharmaceuticals (NASDAQ: VRTX) and Axsome Therapeutics (NASDAQ: AXSM).

Motley Fool 22 days ago

VRTX

AXSM

Performance Overview

Return	VX1.F	S&P 500 (^GSPC)
YTD	-0.46%	+0.92%
1-Year	-9.81%	+12.35%
3-Year	+54.58%	+44.48%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Vertex Pharmaceuticals Incorporated (VX1.F)

2 Top Stocks to Buy Right Now

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

3 Top Growth Stocks to Buy in the Second Half of 2025

2 Monster Growth Stocks to Buy and Hold for 10 Years

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

The Top Corporate Board Directors

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

Exploring High Growth Tech Stocks in the US Market

Value Opportunities: Stocks Estimated Below Intrinsic Worth For May 2025

1 Large-Cap Stock to Target This Week and 2 to Question

Vertex to Participate in Upcoming Investor Conferences

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

2 Biotech Stocks That Are Screaming Buys in May

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Performance Overview